Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study in Healthy People to Test Whether BI 764198 Influences the Amount of Metformin in the Body
Sponsor: Boehringer Ingelheim
Summary
The main objective of this trial is to investigate the effect on the exposure of metformin in plasma when administered as an oral multiple dose together with multiple oral doses of BI 764198 (Test, T) as compared to when metformin is administered as an oral multiple dose alone (Reference, R).
Official title: Investigation of the Effect of BI 764198 on the Pharmacokinetics of Metformin Following Multiple Oral Administration in Healthy Male and Female Trial Participants (an Open-label, Randomised, Two-way Crossover Trial)
Key Details
Gender
All
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
14
Start Date
2026-02-06
Completion Date
2026-03-17
Last Updated
2026-07-06
Healthy Volunteers
Yes
Conditions
Interventions
Metformin hydrochloride
Metformin hydrochloride
BI 764198
BI 764198
Locations (1)
Humanpharmakologisches Zentrum Biberach
Biberach, Germany